Export

ATC codes: L01AX04
EMLc
Indication
Hodgkin lymphoma ICD11 code: 2C10.Z
INN
Dacarbazine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 100 mg in vial powder for injection
EML status history
First added in 1989 (TRS 796)
Changed in 2002 (TRS 914)
Changed in 2007 (TRS 950)
Changed in 2011 (TRS 965)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for dacarbazine on the complementary list of the EML for use in treatment protocols for Hodgkin lymphoma was specifically endorsed and it was added to the complementary list of the EMLc for this indication. The relevant extracts from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Hodgkin lymphoma in adults and in paediatrics are attached.